REPORTS ON SEMINARS

(1) Seminar on "Carcinogenesis and Gene Expression in Liver Cell Culture"
This seminar was held in the East-West Center, University of Hawaii, Honolulu, on November 16-18, 1981. The organizers were Dr. Akira Ichihara, Institute for Enzyme Research, School of Medicine, University of Tokushima, Japan, and Dr. Gary M. Willians, Naylor Dana Institute, Valhalla, New York, U.S.A. There were 18 speakers: 9 from Japan, 8 from the U.S.A. and 1 from France. Use of liver cells in culture for cancer research became very popular recently, but there have been only three international meetings on this subject in the last 10 years. Therefore, it was a suitable time to have a meeting of experts from different countries to exchange information.
At this seminar it became clear that there are three kinds of liver cells in culture and the major object of this seminar was to discuss the specificity of each cell population for studies on hepato carcinogenesis.
One cell population is primary cultured parenchymal hepatocytes. These were shown to retain almost all liver functions and to be able to proliferate under certain conditions. The control mechanism of their cell growth could be compared with that of hepatoma cells. It was shown that hepatoma cells contain some growth promoting factors as well as having lost growth inhibitory factors. These cells can also be used to study the metabolism of carcinogens, their binding with DNA and repair of DNA. Their reactions in vitro mimic very well to those in vivo. Primary cultures of human hepatocytes are also available. It was also shown that parenchymal and non-parenchymal cells could be separated and their functional differences were reported. These studies have contributed much information on the mechanism of carcinogenesis of different liver cell types.
The second cell population is hepatoma cell lines derived from highly differentiated hepatomas. Since these cells retain some liver functions, they are useful for studies of particular liver functions and for comparison with normal hepatocytes. The changes in their properties during carcinogenesis have been shown to be immaturation, retrodifferentiation and fetalism. Recent studies have shown that these changes are due to change of gene expression, not to change in the cell population. Cultured liver cells are very useful for such studies.
The third cell population is epithelial liver cells. They can be isolated easily and established as cell lines. However, they show very few characteristics of liver cells and may be derived from bile ductal cells. There is some possibility that these cells can differentiate into parenchymal hepatocytes in vivo. These epithelial cells were also isolated from preneoplastic nodule of liver induced by administration of carcinogens in vivo and they can be transformed in vitro by addition of various carcinogens including promoters.
These studies on liver cells in culture showed that each cell population has their specificity for studies of hepatocarcinogenesis and that there are some relations of cell lineage among these cell populations. Therefore, they are useful to study various stages of hepatocarcinogenesis from very early initiation stage, preneoplastic stage to late stage.

(2) Seminar on "Intestinal Metaplasia and Stomach Cancer"
"The U.S.-Japan Cooperative Seminar on Intestinal Metaplasia and Stomach Cancer" was held from March 23 to March 25, 1982 at the Shimoda Tokyu Hotel in Shimoda, Shizuoka, Japan. The seminar organizers were Dr. Grant N. Stemmermann of the Kuakini Medical Center in Honolulu, Hawaii, and Dr. Takashi Kawachi of the National Cancer Center Research Institute in Chuo-ku, Tokyo. There were 19 speakers: 13 from Japan and 6 from the United States.
At this conference many aspects of intestinal metaplasia (I.M.) were considered. Various scientific disciplines are being used to study this interesting subject, which is no longer only of interest to pathologists.
Agreement could not be obtained on whether I.M. is a precursor lesion for stomach cancer or only an associated condition. Some speakers believed that a definite precursor relationship could be demonstrated, but others believed no close causative relationship existed. Since causes of stomach cancer are complex, it is reasonable to expect that some cancers can be formed by a process not related to I.M. formation. However, the association of I.M. with many stomach cancers appeared to be strong.
At the conference many discussions were held to develop ways of describing various forms of I.M. Besides the usual microscopic procedures and biochemical enzymatic techniques, new methods using stains for specific types of mucins and immunological procedures were described. While these techniques appeared to be useful, no general agreement was reached at the conference as to how they could be used to distinguish between complete I.M. and incomplete I.M. Several researchers had found different types of classification of I.M. with the hope that these classifications could help to indicate which type is most closely associated with stomach cancer.
Several papers were presented describing how mucosal conversion can result from the process of tissue repair in the gall bladder, small intestine and stomach. In this regard, an interesting finding on the relationship between the mesenchymal and epithelial tissue was presented; namely, that stroma can influence and guide the development of epithelial tissues.
Much progress has been made in the detection of I.M. in the human stomach by endoscopy using methylen blue and other dyes. This technique has many useful applications. It may be capable of detecting various types of I.M. and has been used in extensive screening studies of large populations. It is obvious that many more ways can be developed to use this technique in clinical practice and in research.
The conference showed that many investigators are enthusiastically working in different ways to understand the various aspects of I.M. We believe that the conference was an effective catalyst in stimulating ideas in the minds of the participants.
Unfortunately, Dr. Grant N. Stemmermann, the U.S. organizer of this conference could not attend the meeting at the Shimoda Tokyu Hotel because of his illness. Instead, Dr. Howard Mower served as the U.S. organizer during the conference. Dr. Stemmermann's paper was read by his colleague, Dr. Takuji Hayashi.


SEMINAR AGENDA AND PARTICIPANTS

(1) SEMINAR ON CARCINOGENESIS AND GENE EXPRESSION IN LIVER CELL CULTURES
Honolulu, Hawaii, November 16 to November 18, 1981

AGENDA

Monday, November 16
9:30-10:00 Greetings and Introduction Gary M. Williams
Akira Ichihara
Chairman: G. M. Williams
10:00-10:45 Cell typesin liver culture J. Grisham
10:45-11:30 Growth control of primary cultured rat hepatocytes Akira Ichihara
11:30-12:15 Regulation of retinol binding protein in cultured hepatocytes Carmia Borek
Chairman: V. R. Potter
13:30-14:15 Hormonal responses of mature hepatocytes in primary culture Toshikazu Nakamura
14:15-15:00 Expression of hepatic function in liver epithelial cells; a prospective to serum-free liver cell lines Prudent Padieu
15:00-15:45 Hormontal regulation of liver specific enzymes and desensitization of the effect of glucagon on primary cultured hepatocytes Chiseko Noda

Tuesday, November 17
Chairman: A. Ichihara
9 :30-10:15 Isolation and culture of adult human hepatocytes Ryosaburo Takaki
10:30-11:15 Carcinogen metabolism by isolated hepatocytes James L. Byard
11:15-12:00 Studies on the proliferation and reconfigulation of isolated hepatocytes transplanted into rat spleen Michio Mito
Chairman: M. Mito
13:00-13:45 DNA repair in cultured hepatocytes D. A. Casciano
13:45-14:30 Fractionation of the isolated rat hepatocytes Seishi Nagamori
14:30-15:15 Cell specificity in DNA damage and repair J. Senberg

Wednesday, November 18
Chairman: Tomoyuki Kitagawa
9:30-10:15 Neoplastic transformation in liver epithelial cells Tomiko Shimada
10:15-11:00 Characterization of established cell strains and their spontaneous and chemical malignant transformation in vitro Takayoshi Tokiwa
11:00-11:45 Sensitivity to various hepatotoxins of hepatocytes obtained from carcinogen-treated or promoter treated rat liver Norimasa Sawada
Chairman: J. Grisham
12:30-13:15 Mechanisms of tumor promotion in liver culture G. M. Williams
13:15-14:00 In vitro carcinogenesis of preneoplastic hepatocytes obtained from carcinogen-treated rat liver and effect of promoters Tomoyuki Kitagawa
14:00-14:45 A new protocol and its rationale for the study of carcinogenesis in liver cultures V. R. Potter
14:45-15:00 Summary J. Grisham
15:00-15:30 General discussion
15:30-15:45 Closing remarks G. M. Williams
A. Ichihara

PARTICIPANTS

UNITED STATES
Dr. J. Grisham
Professor and Chairman
Department of Pathology
University of North Carolina
Medical School
Dr. Daniel A. Casciano
Division Director
Division of Mutagenic Research
National Center for Toxicology Research
Dr. Carmia Borek
Department of Radiology
Columbia College of Physicians and Surgeons
Dr. James A. Swenberg
Director of Pathology
Chemical Industry Institute
Dr. James L. Byard
Associate Professor
Department of Environmental Toxicology
University of California, Davis
Dr. Tomiko Shimada
Associate, Division Pathology & Toxicology
Naylor Dana Institute for Disease Prevention
American Health Foundation
Dr. Gary M. Williams
Associate Director
Naylor Dana Institute for Disease Prevention
American Health Foundation
Dr. Van R. Potter
McArdle Laboratory for Cancer Research
University of Wisconsin
JAPAN
Dr. Akira Ichihara
Professor
Institute for Enzyme Research
School of Medicine
University of Tokushima
Dr. Michio Mito
Professor
2nd Department of Surgery
Asahikawa Medical College
Dr. Seishi Nagamori
Research Fellow
Department of the 1st Internal Medicine
Jikei University School of Medicine
Dr. Tomoyuki Kitagawa
Chief, Department of Pathology
Cancer Institute
Dr. Ryosaburo Takaki
Professor
Department of Internal Medicine
Medical College of Oita
Dr. Takayoshi Tokiwa
Lecturer
Cancer Institute
Division of Pathology
Okayama University Medical School
Dr. Toshikazu Nakamura
Assistant Professor
Institute for Enzyme Research
School of Medicine
University of Tokushima
FRANCE
Prof. Prudent Padieu
Chairman, Biochemistry Department
Director of the National Center for Assay and Reference in Mass Spectrometry
Universite de Dijon


(2) SEMINAR ON INTESTINAL METAPLASIA AND STOMACH CANCER
Shimoda, Japan, March 23 to March 25, 1982

AGENDA
Tuesday, March 23
9:00- 9:10 Welcome Address T. Kawachi
H. Mower
Chairman: S. Tannenbaum
9:10-9:30 Histogenesis of Intestinal Metaplasia and its Implication in Carcinogenesis S. Fujita
9:30- 9:40 Discussion
9:40-10:10 Histochemistry of Intestinal Metaplasia of the Stomach S. C. Ming
10:10-10:20 Discussion
10:20-10:40 COFFEE BREAK
10:40-11:10 Polymorphism of Intestinal Metaplasia of the Stomach T. Hayashi
11:10-11:20 Discussion
11:20-11:40 Atypical Epithelium (Adenoma) and Intestinal Metaplasia in Relation with Stomach Cancer T. Hirota
11:40-11:50 Discussion
11:50-12:10 General Discussion
12:00-14:00 LUNCH
Chairman: S. Chun Ming
14:00-14:30 Gastric Metaplasia of the Small Intestine J. Lechago
14:30-14:40 Discussion
14:40-15:00 Antigenic Discrimination between Fetal-type and Adult-type Intestinal Metaplasia of the Stomach T. Mori
15:00-15:10 Discussion
15:10-15:30 COFFEE BREAK
15:30-15:50 Gastric Glycoprotein Antigens and Secretory Component in Intestinal Metaplasia A. Yachi
15:50-16:00 Discussion
16:00-16:30 Diet and Intestinal Metaplasia G. N. Stemmermann
(read by T. Hayashi)
16:30-16:40 Discussion
16:40-17:00 General Discussion
18:30-20:30 RECEPTION

Wednesday, March 24
Chairman: J. Lechago
9:00-9:20 Intestinalization of Embryonic Chicken Stomach Epithelium in Organotypic Culture
T. Mizuno
9:20-9:30 Discussion
9:30-9:50 Role of Stroma in Maintenance and Alteration of Epithelial Structure in Mouse Glandular Stomach T. Sakakura
9:50-10:00 Discussion
10:00-10:30 Experimental Production of Intestinal Metaplasia of the Stomach R. Morgan
10:30-10:40 Discussion
10:40-11:00 COFFEE BREAK
11:00-11:20 Carcinoma and Intestinal Metaplasia in the Gall Bladder K. Sasajima
11:20-11:30 Discussion
11:30-11:50 A Mode of Intestinal Metaplasia in Rats by X-irradiation Alone or in Combination with N-Methyl-N'-nitro-N-nitrosoguanidine H. Watanabe
11:50-12:00 Discussion
12:00-12:20 Gastric Ulcer (Mucosal Regeneration) and Intestinal Metaplasia T. Oohara
12:20-12:30 Discussion
12:30-12:50 General Discussion
Afternoon Informal Discussion (Including Excursion)

Thursday, March 25
Chairman: T. Hayashi
9:00-9:30 Mutagens Associated with Metaplastic and Non-Metaplastic Gastric Mucosa H. Mower
9:30-9:40 Discussion
9:40-10:00 Nitrates and Nitrites in Relation to Intestinal Metaplasia of the Stomach S. Tannenbaum
10:10-10:20 Discussion
10:20-10:40 COFFEE BREAK
10:40-11:00 Endoscopic Diagnosis of Intestinal Metaplasia and its Absorptive Function S. Suzuki
11:00-11:10 Discussion
11:10-11:30 Epidemiology of Intestinal Metaplasia from the View Point of Gastroendoscopy K. Kawai
11:30-11:40 Discussion
11:40-12:00 Pepsinogens I and II in Serum and Intestinal Metaplasia T. Sekine
12:00-12:10 Discussion
12:10-12:30 General Discussion
12:30-12:40 Closing Remarks

PARTICIPANTS

UNITED STATES
Dr. Takuji Hayashi
Department of Pathology
Kuakini Medical Center
Dr. Robin Morgan
Department of Biology
The Johns Hopkins University
Dr. Juan Lechago
Department of Pathology
Harbor General Hospital Division
UCLA School of Medicine
Dr. Howard Mower
Department of Biochemistry and Biophysics
University of Hawaii at Manoa
Dr. S. Chun Ming
Department of Pathology
Temple University Medical School
Dr. Steven R. Tannenbaum
Department of Nutrition and Food Science
Massachusetts Institute of Technology

JAPAN
Dr. Setsuya Fujita
Department of Pathology
Kyoto Prefectural University of Medicine
Dr. Teruyo Sakakura
Laboratory of Experimental Pathology
Aichi Cancer Center Research Institute
Dr. Teruyuki Hirota
Pathology Division
National Cancer Center Research Institute
Dr. Koji Sasajima
Faculty of Surgical Medicine
Nippon Medical School
Dr. Takashi Kawachi
National Cancer Center Research Institute
Dr. Teruaki Sekine
High Risk Study Division
National Cancer Center Research Institute
Dr. Keiichi Kawai
Department of Prevention Medicine
Kyoto Prefectural University of Medicine
Dr. Shigeru Suzuki
Institute of Gastroenterology
Tokyo Women's Medical College
Dr. Takeo Mizuno
Zoological Institute
Faculty of Science
University of Tokyo
Dr. Hiromitsu Watanabe
Department of Cancer Research
Research Institute for Nuclear Medicine and Biology
Dr. Takesada Mori
The Second Department of Surgery
Medical School
Osaka University
Dr. Akira Yachi
Department of Internal Medicine
(Section I)
Sapporo Medical College
Dr. Takeshi Oohara
The Third Department of Surgery
University of Tokyo